Spravato

Spravato vs ketamine: what 8 clinic visits cost in month one

California – November 14, 2026 -- Spravato's first month means eight clinic visits and at least 16 hours of supervised observation, by our calculation from the dosing schedule. A comparison from the NutraBrain clinic and Dr. David Mahjoubi sets Spravato (esketamine) against compounded generic ketamine, which NutraBrain prescribes for home use from $349 a visit.

Spravato is the S enantiomer, one of the two mirror-image molecules in ketamine. The FDA approved it in March 2019 for treatment-resistant depression alongside an oral antidepressant. In 2020 it was also approved for depression with suicidal thoughts, and in January 2025 for use on its own. Ketamine was approved in 1970 as an anesthetic. Prescribing it for depression is off label, and compounded ketamine is not FDA approved.